Vertex Pharmaceuticals Incorporated (VRTX) Balance Sheet Quarterly

Vertex Pharmaceuticals Incorporated

VRTX (NASDAQ)

(%)

Financials
Vertex Pharmaceuticals Incorporated Balance Sheet Statement Quarterly

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2025 (Q3) 09-30	2025 (Q2) 06-30	2025 (Q1) 03-31	2024 (Q4) 12-31	2024 (Q3) 09-30	2024 (Q2) 06-30	2024 (Q1) 03-31
Report Filing:	2025-11-04	2025-08-05	2025-05-06	2025-02-13	2024-11-05	2024-08-02	1234
Total Current Assets	10,570	10,428	10,009	9,596	9,804	8,942	1234
Cash and Short Term Investments	6,287	6,383	6,201	6,116	6,524	5,796	1234
Cash & Equivalents	4,940	4,972	4,675	4,570	5,239	4,580	1234
Short Term Investments	1,347	1,411	1,526	1,546	1,285	1,215	1234
Receivables	1,946	1,894	1,805	1,609	1,751	1,656	1234
Inventory	1,627	1,499	1,360	1,205	1,080	914.6	1234
Other Current Assets	709.4	652.3	642.8	665.7	449.2	575.4	1234
Total Assets	24,862	24,037	22,880	22,533	22,240	20,132	1234
Total Non-Current Assets	14,293	13,609	12,872	12,937	12,436	11,190	1234
Property, Plant and Equipment	3,017	2,649	2,634	2,585	2,514	1,771	1234
Goodwill and Intangible Assets	1,518	1,524	1,529	1,914	1,920	1,926	1234
Goodwill	1,088	1,088	1,088	1,088	1,088	1,088	1234
Intangible Assets	429.8	435.5	441.2	825.9	831.6	837.5	1234
Long Term Investments	5,723	5,646	5,156	5,108	4,704	4,393	1234
Deferred Tax Assets	2,937	2,712	2,544	2,331	2,309	2,186	1234
Other Long Term Assets	1,098	1,079	1,007	999.3	990.2	915.6	1234
Total Current Liabilities	4,475	4,138	3,783	3,565	3,973	3,547	1234
Accounts Payable	4,034	442.3	445	413	395.8	327.9	1234
Notes Payable/Short Term Debt	0	0	0	92.3	0	0	1234
Tax Payables	0	0	0	161.1	0	0	1234
Deferred Revenue	0	0	0	206.8	0	0	1234
Other Current Liabilities	441.5	3,696	3,338	2,691	3,577	3,219	1234
Total Liabilities	7,544	6,861	6,384	6,124	6,609	5,357	1234
Total Non-Current Liabilities	3,068	2,723	2,601	2,559	2,636	1,810	1234
Total Long Term Debt	1,835	1,527	1,649	1,657	1,703	933.4	1234
Deferred Tax Liabilities Non-Current	0	0	0	0	0	0	1234
Deferred Revenue Non-Current	0	0	0	0	0	0	1234
Capital Lease Obligations	1,835	1,527	1,649	1,750	1,703	933.4	1234
Other Long Term Liabilities	-601.4	-331.9	-697.2	-847.7	-769.6	-56.6	1234
Total Equity	17,319	17,175	16,496	16,410	15,631	14,775	1234
Non-Controlling Interest	0	0	0	0	0	0	1234
Total Stockholders' Equity	17,319	17,175	16,496	16,410	15,631	14,775	1234
Retained Earnings	12,369	11,286	10,253	9,607	8,694	7,648	1234
Accumulated Other Earnings	-64.5	-101.1	68.1	127.8	28.8	22.5	1234
Common Stock	2.5	2.6	2.6	2.6	2.6	2.6	1234
Preferred Stock	0	0	0	0	0	0	1234
Additional Paid in Capital	5,012	5,988	6,172	6,672	6,906	7,101	1234
Total Liabilities & Total Equity	24,862	24,037	22,880	22,533	22,240	20,132	1234
Total Liabilities & Shareholders' Equity	24,862	24,037	22,880	22,533	22,240	20,132	1234
Total Investments	7,070	7,056	6,683	6,654	5,989	5,608	1234
Total Debt	1,835	1,527	1,649	1,750	1,703	933.4	1234
Net Debt	-3,105	-3,445	-3,026	-2,820	-3,536	-3,647	1234

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

Vertex Pharmaceuticals Incorporated Balance Sheet Statement Quarterly